- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05275309
Determination of Optimal Positive End-expiratory Pressure Using Electrical Impedance Tomography in Children Under General Anesthesia: Comparison Between Supine and Prone Positions
January 18, 2023 updated by: Hee-Soo Kim, Seoul National University Hospital
The purpose of this study was to determine the appropriate positive end-expiratory pressure (PEEP) using electrical impedance tomography (EIT) in children under general anesthesia and to investigate whether there is a difference between the supine and prone positions.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
33
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 03080
- Hee-Soo Kim
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 1 year (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Children <= years of age who are scheduled for surgery in the prone position under general anesthesia
Exclusion Criteria:
- Respiratory distress, bronchopulmonary dysplasia
- Pneumothorax
- Increased intracranial pressure
- History of airway surgery
- Cervical or thoracic surgery
- Pulmonary hypertension
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Children <= 1 years old
Pediatric patients <= 1 years old of age scheduled for surgery in the prone position
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Optimal PEEP level at spine position
Time Frame: 10 minutes after intubation (supine)
|
Optimal PEEP level (cmH2O) determination using electrical impedance tomography at supine position
|
10 minutes after intubation (supine)
|
|
Optimal PEEP level at prone position
Time Frame: 1 hour after prone positioning (prone)
|
Optimal PEEP level (cmH2O) determination using electrical impedance tomography at prone position
|
1 hour after prone positioning (prone)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dynamic compliance measured using Electrical impedance tomography
Time Frame: until 1 hour after prone positioning
|
ventilation/pressure (ml/cmH2O)
|
until 1 hour after prone positioning
|
|
regional ventilation delay measured using Electrical impedance tomography
Time Frame: until 1 hour after prone positioning
|
ventilation time delay during one breath (no unit)
|
until 1 hour after prone positioning
|
|
pulmonary opening pressure measured using Electrical impedance tomography
Time Frame: until 1 hour after prone positioning
|
alveoli opening pressure (cmH2O)
|
until 1 hour after prone positioning
|
|
atelectasis/overdistension ratio measured using Electrical impedance tomography
Time Frame: until 1 hour after prone positioning
|
The degree comparing atelectasis and overdistension (no unit)
|
until 1 hour after prone positioning
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 14, 2022
Primary Completion (Actual)
December 30, 2022
Study Completion (Actual)
December 30, 2022
Study Registration Dates
First Submitted
November 19, 2021
First Submitted That Met QC Criteria
March 1, 2022
First Posted (Actual)
March 11, 2022
Study Record Updates
Last Update Posted (Actual)
January 20, 2023
Last Update Submitted That Met QC Criteria
January 18, 2023
Last Verified
November 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- H2111-072-1272
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.